Cohance Lifesciences Limited (BOM:543064)
India · Delayed Price · Currency is INR 433.25
+9.65 (2.28%)
At close: Sep 16, 2026
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 162.06 billion as of September 16, 2026. Its market cap has decreased by -56.79% in one year.
Market Cap
162.06B
Enterprise Value
164.03B
Revenue
21.42B
Ranking
n/a
PE Ratio
152.55
Stock Price
433.25
ChartMarket Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 162.06B, an increase of 480,705.34%. That is a compound annual growth rate of 266.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 162.06B | -19.86% |
| Dec 31, 2025 | 202.22B | -30.24% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 216.20B |
| Caplin Point Laboratories | 195.41B |
| AstraZeneca Pharma India | 167.33B |
| Jubilant Pharmova | 159.91B |
| Viyash Scientific | 107.87B |
| Procter & Gamble Health | 90.04B |
| Bliss GVS Pharma | 72.94B |